Aytu Biopharma (AYTU) Other Operating Expenses (2010 - 2026)
Aytu Biopharma (AYTU) posted quarterly Other Operating Expenses of $6.7 million for Q1 2026, up 518.3% year-over-year from $1.1 million in Q1 2025, and up 1171.86% quarter-over-quarter from $526000.0 in Q4 2025.
Aytu Biopharma (AYTU) Other Operating Expenses (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Other Operating Expenses for 17 consecutive years, with $6.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 518.3% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $36.6 million (up 231.04% YoY), while the FY2025 annual figure was $32.9 million, up 409.18% from the prior year.
- Other Operating Expenses improved to $6.7 million in Q1 2026 per AYTU's latest filing, from $526000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $48.7 million in Q1 2022 and bottomed at -$4.9 million in Q2 2022.
- Historically, Other Operating Expenses has averaged $8.8 million across 5 years, with a median of $6.3 million in 2024.
- Annual changes were most pronounced in 2022 — Other Operating Expenses plunged 627.6% — and 2025, when it surged 1376.31%.
- Aytu Biopharma's Other Operating Expenses stood at $14.4 million in 2022, then plunged by 57.49% to $6.1 million in 2023, then tumbled by 76.48% to $1.4 million in 2024, then slumped by 63.55% to $526000.0 in 2025, then soared by 1171.86% to $6.7 million in 2026.
- Business Quant data shows AYTU's Other Operating Expenses at $6.7 million in Q1 2026, $526000.0 in Q4 2025, and $444000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.69 Mn |
| Dec 31, 2025 | 526,000.00 |
| Sep 30, 2025 | 444,000.00 |
| Jun 30, 2025 | 28.98 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | 6.58 Mn |
| Jun 30, 2024 | 1.96 Mn |
| Mar 31, 2024 | 6.27 Mn |
| Dec 31, 2023 | 6.14 Mn |
| Sep 30, 2023 | 7.02 Mn |
| Jun 30, 2023 | 11.82 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 14.43 Mn |
| Sep 30, 2022 | 11.45 Mn |
| Jun 30, 2022 | -4.90 Mn |
| Mar 31, 2022 | 48.75 Mn |
| Dec 31, 2021 | 5.98 Mn |
| Sep 30, 2021 | 22.64 Mn |
| Jun 30, 2021 | -674,000.00 |